MU
Micron Technology, Inc.
MU has the edge over NCNO overall, supported by stronger valuation and stronger modeled upside.
NCNO
nCino, Inc.
NCNO's outlook is improving, though it still trails on the overall score.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
NCNO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Stable |
NCNO's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
NCNO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $22.36 | — |
| Cheap | 72x | $21.56 | -3.6% |
| Current | 75x | $22.36 | — |
| Fair | 133x | $40.02 | +79% |
| Expensive | 333x | $99.88 | +347% |
Historical ranges are pointers, not guarantees.
NCNO has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
NCNO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for NCNO, with profitability improving.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over NCNO on earnings, with more consistent year-over-year improvement.
NCNO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.51 | +405% |
| Q3 2026 | $0.30 | +$0.58 |
| Q2 2026 | $0.12 | +$0.37 |
| Q1 2026 | $0.05 | +$0.38 |
| Q4 2025 | -$0.17 | $0.00 |
| Q3 2025 | -$0.28 | -$0.01 |
| Q2 2025 | -$0.25 | +$0.06 |
| Q1 2025 | -$0.33 | +$0.05 |
| Q4 2024 | -$0.17 | +$0.41 |
NCNO has returned to profit: it earned $0.30 per share over the past year, after losing money the year before.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over NCNO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over NCNO on profitability, with a higher operating margin.
NCNO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $161M | +8.2% |
| Q2 2026 | $159.4M | +11% |
| Q1 2026 | $149.7M | +5.9% |
| Q4 2025 | $152.2M | +9.6% |
| Q3 2025 | $148.8M | +12% |
| Q2 2025 | $144.1M | +13% |
| Q1 2025 | $141.4M | +14% |
| Q4 2024 | $138.8M | +14% |
NCNO's revenue has grown year over year every quarter since late 2020: $161M last quarter, up 8.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.5% | +15 points |
| Q2 2026 | 13% | +14 points |
| Q1 2026 | 1.9% | +5.9 points |
| Q4 2025 | 7.7% | +8.3 points |
| Q3 2025 | -6.3% | -0.3 points |
| Q2 2025 | -1.1% | +1.8 points |
| Q1 2025 | -4.1% | -1.5 points |
| Q4 2024 | -0.6% | +10 points |
NCNO's operating margin was 8.5% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over NCNO on cash flow, with more consistent year-over-year improvement.
NCNO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $34M | +170% |
| Q2 2026 | $80.8M | +54% |
| Q1 2026 | $12.5M | +$22.8M |
| Q4 2025 | $4.9M | -3.9% |
| Q3 2025 | $12.6M | +176% |
| Q2 2025 | $52.6M | -2.8% |
| Q1 2025 | -$10.4M | -234% |
| Q4 2024 | $5.1M | -2.9% |
NCNO generated $132M in free cash flow over the past year, up 121% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
NCNO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.7% | -4.1M shares |
| 1 year | -8.6% | -9.9M shares |
| 3 years | -6.3% | -7M shares |
| 5 years | +10% | +9.7M shares |
| Available history | +18% | +15.7M shares |
NCNO has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $65.6M |
| Q2 2026 | $110.1M |
| Q1 2026 | $25M |
| Q4 2025 | $39.5M |
| Q3 2025 | $20M |
| Q2 2025 | $40.6M |
| Q1 2022 | — |
| Q4 2021 | — |
NCNO spent $240M buying back its own shares over the past year.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over NCNO on leverage, with a lower net debt burden relative to earnings.
NCNO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 3.1x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.3x | Elevated |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | -5.0x | Net Cash |
NCNO's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
NCNO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.1 | Neutral |
| Stochastic | 77.0 | Neutral |
NCNO's weekly RSI is 58 (neutral) and its Stochastic is 77 (neutral).
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over NCNO on valuation relative to its sector.
NCNO PE vs Technology Sector
| Metric | NCNO | Sector median | Relative |
|---|---|---|---|
| PE | 75x | 28x | 168% above |
| PE % | 19 | 37 | 18 pts below |
NCNO is trading at 75x earnings, a 168% premium to the Technology sector's median of 28x, though its earnings don't support one.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
NCNO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 5.7% above |
| 20 week MA | $20.3 | 10% above |
| 50 week MA | $19.4 | 15% above |
| 100 week MA | $23.8 | 6.2% below |
| 200 week MA | $27.2 | 18% below |
NCNO has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 18% below its 200-week average.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over NCNO on returns for 2026, with the stronger performance.
NCNO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $74.0 | $78.7 | +6.3% |
| 2021 | $78.7 | $57.0 | -28% |
| 2022 | $57.0 | $25.9 | -55% |
| 2023 | $25.9 | $33.6 | +30% |
| 2024 | $33.6 | $34.4 | +2.4% |
| 2025 | $34.4 | $26.3 | -24% |
| 2026 YTD | $26.3 | $22.4 | -15% |
NCNO has finished lower in three of the last six years. It's down 15% so far in 2026.